I Use Ketamine for Depression – Here’s How It Works.

FREETHINK: When first manufactured as an anesthetic for humans and animals in 1962, doctors had no intention of prescribing ketamine for depression....
ehave, ehvvf

Ehave (EHVVF) Looks to Power the Psychedelics Revolution

Mental illness will cost the global economy $16 trillion by 2030 due to early-onset and lost productivity, with an estimated 12 billion working days...
Psychedelic Stock Review

Ehave (EVVHF) Hires Institutional Review Board (IRB) As It Solidifies Partnership With Tristar Wellness...

Institutional Review Board (IRB) reviews proposed research protocols to protect human subjects involved in research. MIAMI, July 09,...
Psychedelic Stock Review

Psychedelic Investor Conferences.

Not Quite as Popular as the Bitcoin 2021 Conference Attended by 12,000 - But Worth Considering!
Psychedelic Stock Review

Psychedelic Primer Guide. (Psychedelic Medicine Association)

The Psychedelic Medicine Association (PMA) is a society of physicians, therapists, and health care professionals looking to advance their education on the...
Greenbrook Health

Greenbrook Health Centers (GBNH) Changing the Way Depression is Treated.

Cybin Enters into Collaboration Agreement with Greenbrook TMS to Establish Mental Health Centers of Excellence https://youtu.be/yrr-wlFftT0
ehave, psychedelic stock review

Adding Ehave (EHVFF) $0.04 to Psychedelic Watch List.

Mental Health and Wellness Incubator Set to Launch Four Initiatives.Trading at Year Low. Launching Clinical Trial With Brain Scientific to Monitor Ketamine...

The FDA Cracks Down On Stem Cell Therapy.

Due to a somewhat unexpected crackdown on stem cell treatment centers a couple of weeks ago - we have decided to hold...

The Psychedelic Revolution Is Coming. Psychiatry May Never Be the Same (New York Times).

Summary: MAPS is featured in an article on the front page of today's edition of The New York Times!
psychedelic stock review

Advances in Psychedelics can Change Investors’ Minds

Original article(s) on EXBulletin and Financial Times The science behind this subject has become mainstream in recent years. Excellent...

Latest article

Nine Page Summary Report on GeoVax (GOVX)

This is a great long-term story. We’re telling you. (March 2024) When we finished writing our earlier...

GeoVax (GOVX) Provides First Half 2024 Business Update.

Award of BARDA Project NextGen contract represents a significant milestone event; Total value...

Reverse Split Mania! Solgenix (SNGX) Jumps 448% After 1:16.

Can You Imagine Selling Solgenix at $2.00 yesterday. And to be honest, news wasn't all that big - such...